Analyst Recommendations

Mizuho Securities analyst issues BUY recommendation for CI on February 5, 2024 12:39PM ET. The previous analyst recommendation was Buy.CI was trading at $323.34 at issue of the...

February 5, 2024   CI -2.01%

Piper Sandler analyst issues OVERWEIGHT recommendation for TSLA on February 5, 2024 12:22PM ET. The previous analyst recommendation was Overweight.TSLA was trading at $181.5561 at issue of the...

February 5, 2024   TSLA 6.69%

Cowen & Co. analyst issues OUTPERFORM recommendation for MCD on February 5, 2024 11:13AM ET. The previous analyst recommendation was Outperform.MCD was trading at $285.1899 at issue of...

February 5, 2024   MCD -0.40%

Cowen & Co. analyst issues OUTPERFORM recommendation for MCD on February 5, 2024 11:13AM ET. The previous analyst recommendation was Outperform.MCD was trading at $285.1899 at issue of...

February 5, 2024   MCD -0.40%

Stephens analyst issues OVERWEIGHT recommendation for MCD on February 5, 2024 11:13AM ET. The previous analyst recommendation was Overweight.MCD was trading at $285.134 at issue of the analyst...

February 5, 2024   MCD -0.40%

UBS analyst issues BUY recommendation for MNDY on February 5, 2024 10:00AM ET. The previous analyst recommendation was Buy.MNDY was trading at $210.225 at issue of the analyst...

February 5, 2024   MNDY 3.42%

UBS analyst issues NEUTRAL recommendation for RSKD on February 5, 2024 09:01AM ET. The previous analyst recommendation was Neutral.RSKD was trading at $4.62 at issue of the analyst...

February 5, 2024   RSKD 2.34%

Wells Fargo analyst issues BUY recommendation for EXPE on February 5, 2024 09:00AM ET. The previous analyst recommendation was Buy.EXPE was trading at $149.27 at issue of the...

February 5, 2024   EXPE -0.72%

Barclays analyst issues OVERWEIGHT recommendation for ABBV on February 5, 2024 08:50AM ET. The previous analyst recommendation was Overweight.ABBV was trading at $168.67 at issue of the analyst...

February 5, 2024   ABBV -2.42%

Oppenheimer analyst issues OUTPERFORM recommendation for CBOE on February 5, 2024 08:45AM ET. The previous analyst recommendation was Outperform.CBOE was trading at $182.78 at issue of the analyst...

February 5, 2024   CBOE -1.57%